Healthcare industry

Article - 22/03/2010

IBR Inc.: Dual strategy for safe and effective drugs

IBR Inc. a science-based provider of preclinical and clinical services specialises in inflammatory diseases. The analyses it carries out for the pharmaceutical and biotech sector help exclude potential side effects of specific drug candidates early in the development process.

Article - 13/03/2010

Assembling life from building blocks?

As part of its “Bioethics Forum”, the German Ethics Council recently held a meeting in Berlin to inform the public about the fundamentals of synthetic biology and potential ethical problems and consequences in terms of our ideas about life and mankind in general arising from the progress made in this new field of research.

Article - 05/11/2009

CLAIR provides new insights

The human eye is a fascinating organ as well as model for the specialists at Stockach-based Sensovation AG. Their complex optical detection systems are based on CCD and CMOS technologies. However a high-tech sensor is able to recognise much more than many eyes put together.

Press release - 13/10/2009

Trenzyme receives ISO 9001 certification

The Trenzyme GmbH has set another milestone as a first class service provider for the pharma and life science industry.

Press release - 09/10/2009

BIOTECHNICA 2009 - turning ideas into value

BIOTECHNICA 2009 which took place in Hanover Germany from 6th to 8th October 2009 featured the seminal motto Turning ideas into value. The exhibition programme was rounded off by numerous talks and plenary discussions held at the joint Baden-Württemberg booth.

Article - 14/09/2009

SensScreen Technologies: Magnetic separation to conquer biotechnological areas of application

In terms of protein purification, the biopharmaceutical industry is increasingly reaching its technical and economic limits. The currently used chromatography procedures are expensive, time-consuming and associated with high product losses due to the large number of individual processing steps involved. Special magnetic microparticles, such as those developed by the chemist Dr. Jochen F. Peter with his recently established company SensScreen…

Article - 30/07/2009

Dragnet investigation for substance killers

The Ulm-based company Labor Dr. Merk Kollegen with over 40 employees is a specialist company identifying foreign bodies such as viruses bacteria and toxins in biopharmaceuticals and medical products. In addition the medium-sized company has been developing producing and marketing diagnostics for medical use for almost 40 years.

Article - 30/07/2009

Keeping as many valuable attachments as possible

The goal of many projects focusing on the purification of recombinant proteins is to rapidly and effectively remove substances and side products that would compromise the quality and quantity of biopharmaceutical compounds. A consortium of industrial and scientific partners is currently focusing on a different step in the biopharmaceutical production process: the goal is to keep as many as possible of the drugs’ ‘attachments’. The project focuses…

febit holding gmbh announced today the launch of the first human cancer biochip for HybSelectâ, febit’s highly automated technology for sequence capture, enabling targeted Next-Generation Sequencing (NGS). The new catalog cancer biochip features 115 important genes which are reported to be associated with common types of cancer by the Wellcome Trust Sanger Institute.

Press release - 30/06/2009

febit First to Offer Newly Published Mouse Genome on a Chip for DNA/RNA Detection and Enrichment

In the near future, Next-Generation Sequencing technologies will lead to a rising number of completed genomes of model organisms and other species of interest, as demonstrated by the updated mouse genome. This accelerated development will generate a variety of tools available in the short term for the application of the new data into experiments. febit’s technology enables the conversion of new sequence data into biochips for gene expression…

Press release - 01/05/2009

Gaining insights into potato cells

Viruses and bacteria are the lifeblood of GATC a family-run biotechnology company that is continuing to grow in spite of the current economic downturn. At the moment GATC is working on the sequence of one particular vegetable - and the company has submitted a building application to add another 1000 square metres to the existing 800.

Press release - 02/04/2009

J&M Analytik awarded VR-Mittelstand Innovation Prize

The main prize a cheque for 25000 euros was awarded to Essingen-based JM Analytik AG for its development of the Lighthouse ProbeTM Technology an innovative probe technology with integrated cleaning function for use in process analytics. The fully automated optical method can be used to monitor production processes.

Although there is very little difference between the biotechnological methods used in the dairy industry and those used in other industries nevertheless biotechnology operates differently here. Why can certain goals sometimes be reached more effectively without academic research?

Dossier - 29/03/2009

Options for the food industry

Biotechnology has since found its way into the food industry and in fact into the entire value creation chain from raw material production to food processing to the sale of the final product. There are many ways in which biotechnology can contribute to better food products. These include the use of enzymes and microorganisms as well as in the production of food supplements and to improve analytic tests.

Press release - 26/03/2009

5 million euros for expansion

KfW Mittelstandsbank and Zukunftsfonds Heilbronn will invest 5 million euros in Tübingen-based PANATecs GmbH. PANATecs provides products and services for the pharmaceutical industry and will use the financial injection to expand and invest in modern analysis technologies such as high-mass spectrometry.

Press release - 17/03/2009

The market for analytical, bio- and laboratory technology in Germany still doing well

German manufacturers of analytical, bio- and laboratory technologies achieved considerable growth in 2008, and the sector is cautiously optimistic about 2009. According to calculations produced by the SPECTARIS industry association, this industry sector (about 330 companies) achieved sales revenues in 2008 that were about eight percent higher (up 6.2 billion euros) than in 2007.

Article - 09/02/2009

Bodo Philipp – the discovery of the general principles of bacterial interaction

Dr. Bodo Philipp from the University of Constance specifically focuses on ecologically relevant activities of bacteria for example cell-cell interactions. His findings could prove effective in removing bacteria from areas where high levels of hygiene are required thereby making it possible to prevent life-threatening bacterial infectious diseases. Dr. Bodo Philipp uses the much feared Pseudomonas aeruginosa bacteria as model organisms for his…

Press release - 08/01/2009

ILM – Applicators and method development

The ILM offers a broad range of services relating to the development of devices and methods. The service offer comprises the entire value creation chain from the initial solution concept to the applicable functional model.

Press release - 08/01/2009

ILM – Screening methods

Optical screening methods are of huge importance for a broad range of analytical issues. Fluorescence-based methods are highly significant for their high sensitivity amongst other things. Important technological developments have focused for example on reducing sample volumes increasing sample throughput high-throughput screening HTC or on information content high-content screening HCS. With regard to screening methods the ILM is currently…

Press release - 08/01/2009

ILM – Optical analytics

In collaboration with the company Labor Dr. Merk & Kollegen GmbH and the Institute of Virology at the University of Ulm, the ILM is developing an innovative detection system for the early diagnosis of influenza virus infections in pharyngeal secretions.

Press release - 01/11/2008

Boris Mizaikoff and Christine Kranz – on the way to systems analytics

The two chemists Boris Mizaikoff and Christine Kranz have a great deal in common they are married to each other they have children together and they work at the same university on projects that combine technologies and methods to create multifunctional analytical platforms at the Department of Analytical and Bioanalytical Chemistry at Ulm University.

Prof. Dr. Michael Reth is active in the field of immunology and signalling. He is an experienced scientist who is well aware of the difficulty and the cumbersome nature of deciphering signals and signalling pathways. The Freiburg bioss excellence cluster - the Centre of Biological Signalling Studies - is Reths brainchild. Karin Bundschuh from BioRegio Freiburg spoke with the scientist who works at the Max Planck Institute of Immunobiology and the…

In the EU it is mandatory to adequately label genetically modified food or animal feed. But how can producers make sure that their products are free from genetically modified organisms? The company Eurofins GeneScan GmbH from Freiburg can help.

The new drug screening and safety pharmacology laboratory at NMI Technologie Transfer GmbH NMI TT GmbH in Reutlingen with its standardised and special test systems complies fully with the requirements of safety pharmacology tests.

Article - 17/06/2008

"Study and work abroad!”"

Quick practically oriented and above all international The new bachelor and masters degrees in the natural sciences have been introduced to bring German university qualifications into line with the requirements of the international job market as well as to facilitate the uncomplicated exchange of scientists across the globe. However not everything always works out as planned. Research abroad is often limited by time and money.